Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oral piritrexim--a phase II study in patients with advanced soft tissue sarcoma.

× No keyword cloud information.

4 in total

Review 1. Chemotherapy of advanced soft tissue and osteosarcomas.

Authors: M J Kane
Journal: Semin Oncol Date: 1989-08 Impact factor: 4.929

2. Initial clinical studies of piritrexim.

Authors: J Laszlo; W D Brenckman; E Morgan; N J Clendeninn; T Williams; V Currie; C Young
Journal: NCI Monogr Date: 1987

3. Selective toxicity of a new lipophilic antifolate, BW301U, for methotrexate-resistant cells with reduced drug uptake.

Authors: I W Taylor; P Slowiaczek; M L Friedlander; M H Tattersall
Journal: Cancer Res Date: 1985-03 Impact factor: 12.701

4. Preclinical biochemical pharmacology and toxicology of piritrexim, a lipophilic inhibitor of dihydrofolate reductase.

Authors: C W Sigel; A W Macklin; J L Woolley; N W Johnson; M A Collier; M R Blum; N J Clendeninn; B J Everitt; G Grebe; A Mackars
Journal: NCI Monogr Date: 1987

4 in total

3 in total

1. Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder.

Authors: M Khorsand; J Lange; L Feun; N J Clendeninn; M Collier; G Wilding
Journal: Invest New Drugs Date: 1997 Impact factor: 3.850

Review 2. From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates.

Authors: Jackie Walling
Journal: Invest New Drugs Date: 2006-01 Impact factor: 3.651

3. A phase II study of oral piritrexim in recurrent high-grade (III, IV) glioma.

Authors: N M Bleehen; H V Newman; R P Rampling; J R Ramsay; J T Roberts; P Bedford; A B Nethersell
Journal: Br J Cancer Date: 1995-09 Impact factor: 7.640

3 in total